C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 217/18 (2006.01) A61K 31/472 (2006.01) A61K 31/4725 (2006.01) A61P 3/10 (2006.01) C07D 217/22 (2006.01) C07D 217/26 (2006.01) C07D 401/04 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 405/10 (2006.01) C07D 409/10 (2006.01) C07D 413/06 (2006.01) C07D 417/06 (2006.01)
Patent
CA 2524958
Compounds of formula (I) are provided as well as pharmaceutically acceptable salts and esters thereof, wherein the substituents are as disclosed in the specification. The compounds have utility for the treatment of type 2 diabetes mellitus.
L'invention porte sur des composés de formule (I) et sur leurs sels et esters pharmacocompatibles, dont les substituants sont définis dans les spécifications. Lesdits composés sont utiles pour le traitement du diabète sucré de type 2.
Bolin David Robert
Chen Shaoqing
Mischke Steven Gregory
Qian Yimin
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Isoquinoline derivatives and their use as gfat inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoquinoline derivatives and their use as gfat inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinoline derivatives and their use as gfat inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1485852